Supramolecular immunotherapy on diversiform immune cells.

Area of Science:

• Biomaterials Science
• Immunology
• Oncology

Background:

• Supramolecular immunotherapy leverages supramolecular materials to modulate the immune system for cancer treatment.
• This approach aims to inhibit tumor growth, metastasis, and recurrence, enhancing patient survival and quality of life.

Purpose of the Study:

• To outline the fundamentals of supramolecular immunotherapy.
• To discuss the advantages of targeting immune cells with supramolecular drugs.
• To review current research advances and future potential.

Main Methods:

• Review of supramolecular material construction and therapeutic benefits.
• Analysis of supramolecular drug targeting to various immune cells.
• Compilation of laboratory and clinical research findings.

Main Results:

• Supramolecular materials offer unique advantages in stimulating anti-tumor immune responses.
• Targeting specific immune cells with supramolecular drugs enhances therapeutic efficacy.
• Current research demonstrates significant progress in preclinical and clinical settings.

Conclusions:

• Supramolecular immunotherapy holds immense promise for effective cancer treatment.
• Further development is needed to overcome challenges and realize its full potential.
• This field offers exciting opportunities for innovation in oncology.